California 2019-2020 Regular Session

California Senate Bill SCR64 Compare Versions

OldNewDifferences
1-Senate Concurrent Resolution No. 64 CHAPTER 141Relative to drug abuse. [ Filed with Secretary of State September 09, 2019. ] LEGISLATIVE COUNSEL'S DIGESTSCR 64, Bates. Drug abuse awareness.This measure would designate the month of September 2019 as Opioid, Heroin, Fentanyl, and Prescription Drug Abuse Awareness Month, as specified.Digest Key Fiscal Committee: NO Bill TextWHEREAS, Opioids are drugs that act on the nervous system to conceal pain; andWHEREAS, Between 2006 and 2012, pharmaceutical companies produced 76 billion opioids that were distributed in the United States; andWHEREAS, In 2017, more than 21 million opioid prescriptions were written in California; andWHEREAS, From 1999 to 2017, inclusive, almost 400,000 people died from overdoses related to opioids; andWHEREAS, In 2017, 47,600 deaths in the United States were caused by a drug overdose involving opioids; andWHEREAS, Drug overdoses kill more people in one year than do the number of motor vehicle fatalities in the United States; andWHEREAS, The use of fentanyl is on the rise, with nearly seven times more confiscations of fentanyl from 2012 to 2014, inclusive, totaling 4,585 in 2014, according to the National Forensic Laboratory Information System; andWHEREAS, Fentanyl is 50 times more potent than heroin and 100 times more powerful than morphine, according to the federal Centers for Disease Control and Prevention; andWHEREAS, Aggregate annual costs for prescription opioid overdose, abuse, and dependence were estimated at over $78.5 billion in 2013; andWHEREAS, Abuse of opioid pain relievers is the strongest risk factor for heroin abuse; andWHEREAS, Seventy-five percent of new heroin users were first addicted to a legally prescribed prescription opioid; andWHEREAS, Many teens and young adults first use opioids when they are prescribed to them following an injury or routine procedure like the removal of wisdom teeth; andWHEREAS, Each day in the United States, 580 people initiate heroin use; andWHEREAS, Opioid use and misuse can create brain changes that lead to addiction; andWHEREAS, Most people who are addicted to opioids cannot taper off, or use less of the drug over time, without help; andWHEREAS, The long-term damage to individuals and families is highly detrimental; andWHEREAS, The Centers for Disease Control and Prevention recommends nonopioid pharmacologic therapy and if opioids are used, they should be combined with nonopioid therapy, as appropriate; andWHEREAS, In 2016, the federal Interagency Pain Research Coordinating Committee developed a National Pain Strategy, noting that effective pain care must emphasize shared decisionmaking, informed pain assessment, and integrated, multimodal, and interdisciplinary treatment approaches that balance effectiveness with safety; andWHEREAS, Each year, a week in September is designated as national Prescription Opioid and Heroin Epidemic Awareness Week; now, therefore, be itResolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature designates the month of September 2019 as Opioid, Heroin, Fentanyl, and Prescription Drug Abuse Awareness Month and encourages residents to show support for opioid and prescription drug awareness; and be it furtherResolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
1+Enrolled September 03, 2019 Passed IN Senate August 19, 2019 Passed IN Assembly August 30, 2019 CALIFORNIA LEGISLATURE 20192020 REGULAR SESSION Senate Concurrent Resolution No. 64Introduced by Senators Bates and HillAugust 12, 2019Relative to drug abuse.LEGISLATIVE COUNSEL'S DIGESTSCR 64, Bates. Drug abuse awareness.This measure would designate the month of September 2019 as Opioid, Heroin, Fentanyl, and Prescription Drug Abuse Awareness Month, as specified.Digest Key Fiscal Committee: NO Bill TextWHEREAS, Opioids are drugs that act on the nervous system to conceal pain; andWHEREAS, Between 2006 and 2012, pharmaceutical companies produced 76 billion opioids that were distributed in the United States; andWHEREAS, In 2017, more than 21 million opioid prescriptions were written in California; andWHEREAS, From 1999 to 2017, inclusive, almost 400,000 people died from overdoses related to opioids; andWHEREAS, In 2017, 47,600 deaths in the United States were caused by a drug overdose involving opioids; andWHEREAS, Drug overdoses kill more people in one year than do the number of motor vehicle fatalities in the United States; andWHEREAS, The use of fentanyl is on the rise, with nearly seven times more confiscations of fentanyl from 2012 to 2014, inclusive, totaling 4,585 in 2014, according to the National Forensic Laboratory Information System; andWHEREAS, Fentanyl is 50 times more potent than heroin and 100 times more powerful than morphine, according to the federal Centers for Disease Control and Prevention; andWHEREAS, Aggregate annual costs for prescription opioid overdose, abuse, and dependence were estimated at over $78.5 billion in 2013; andWHEREAS, Abuse of opioid pain relievers is the strongest risk factor for heroin abuse; andWHEREAS, Seventy-five percent of new heroin users were first addicted to a legally prescribed prescription opioid; andWHEREAS, Many teens and young adults first use opioids when they are prescribed to them following an injury or routine procedure like the removal of wisdom teeth; andWHEREAS, Each day in the United States, 580 people initiate heroin use; andWHEREAS, Opioid use and misuse can create brain changes that lead to addiction; andWHEREAS, Most people who are addicted to opioids cannot taper off, or use less of the drug over time, without help; andWHEREAS, The long-term damage to individuals and families is highly detrimental; andWHEREAS, The Centers for Disease Control and Prevention recommends nonopioid pharmacologic therapy and if opioids are used, they should be combined with nonopioid therapy, as appropriate; andWHEREAS, In 2016, the federal Interagency Pain Research Coordinating Committee developed a National Pain Strategy, noting that effective pain care must emphasize shared decisionmaking, informed pain assessment, and integrated, multimodal, and interdisciplinary treatment approaches that balance effectiveness with safety; andWHEREAS, Each year, a week in September is designated as national Prescription Opioid and Heroin Epidemic Awareness Week; now, therefore, be itResolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature designates the month of September 2019 as Opioid, Heroin, Fentanyl, and Prescription Drug Abuse Awareness Month and encourages residents to show support for opioid and prescription drug awareness; and be it furtherResolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
22
3- Senate Concurrent Resolution No. 64 CHAPTER 141Relative to drug abuse. [ Filed with Secretary of State September 09, 2019. ] LEGISLATIVE COUNSEL'S DIGESTSCR 64, Bates. Drug abuse awareness.This measure would designate the month of September 2019 as Opioid, Heroin, Fentanyl, and Prescription Drug Abuse Awareness Month, as specified.Digest Key Fiscal Committee: NO
3+ Enrolled September 03, 2019 Passed IN Senate August 19, 2019 Passed IN Assembly August 30, 2019 CALIFORNIA LEGISLATURE 20192020 REGULAR SESSION Senate Concurrent Resolution No. 64Introduced by Senators Bates and HillAugust 12, 2019Relative to drug abuse.LEGISLATIVE COUNSEL'S DIGESTSCR 64, Bates. Drug abuse awareness.This measure would designate the month of September 2019 as Opioid, Heroin, Fentanyl, and Prescription Drug Abuse Awareness Month, as specified.Digest Key Fiscal Committee: NO
44
5- Senate Concurrent Resolution No. 64 CHAPTER 141
5+ Enrolled September 03, 2019 Passed IN Senate August 19, 2019 Passed IN Assembly August 30, 2019
66
7- Senate Concurrent Resolution No. 64
7+Enrolled September 03, 2019
8+Passed IN Senate August 19, 2019
9+Passed IN Assembly August 30, 2019
810
9- CHAPTER 141
11+ CALIFORNIA LEGISLATURE 20192020 REGULAR SESSION
12+
13+ Senate Concurrent Resolution
14+
15+No. 64
16+
17+Introduced by Senators Bates and HillAugust 12, 2019
18+
19+Introduced by Senators Bates and Hill
20+August 12, 2019
1021
1122 Relative to drug abuse.
12-
13- [ Filed with Secretary of State September 09, 2019. ]
1423
1524 LEGISLATIVE COUNSEL'S DIGEST
1625
1726 ## LEGISLATIVE COUNSEL'S DIGEST
1827
1928 SCR 64, Bates. Drug abuse awareness.
2029
2130 This measure would designate the month of September 2019 as Opioid, Heroin, Fentanyl, and Prescription Drug Abuse Awareness Month, as specified.
2231
2332 This measure would designate the month of September 2019 as Opioid, Heroin, Fentanyl, and Prescription Drug Abuse Awareness Month, as specified.
2433
2534 ## Digest Key
2635
2736 ## Bill Text
2837
2938 WHEREAS, Opioids are drugs that act on the nervous system to conceal pain; and
3039
3140 WHEREAS, Between 2006 and 2012, pharmaceutical companies produced 76 billion opioids that were distributed in the United States; and
3241
3342 WHEREAS, In 2017, more than 21 million opioid prescriptions were written in California; and
3443
3544 WHEREAS, From 1999 to 2017, inclusive, almost 400,000 people died from overdoses related to opioids; and
3645
3746 WHEREAS, In 2017, 47,600 deaths in the United States were caused by a drug overdose involving opioids; and
3847
3948 WHEREAS, Drug overdoses kill more people in one year than do the number of motor vehicle fatalities in the United States; and
4049
4150 WHEREAS, The use of fentanyl is on the rise, with nearly seven times more confiscations of fentanyl from 2012 to 2014, inclusive, totaling 4,585 in 2014, according to the National Forensic Laboratory Information System; and
4251
4352 WHEREAS, Fentanyl is 50 times more potent than heroin and 100 times more powerful than morphine, according to the federal Centers for Disease Control and Prevention; and
4453
4554 WHEREAS, Aggregate annual costs for prescription opioid overdose, abuse, and dependence were estimated at over $78.5 billion in 2013; and
4655
4756 WHEREAS, Abuse of opioid pain relievers is the strongest risk factor for heroin abuse; and
4857
4958 WHEREAS, Seventy-five percent of new heroin users were first addicted to a legally prescribed prescription opioid; and
5059
5160 WHEREAS, Many teens and young adults first use opioids when they are prescribed to them following an injury or routine procedure like the removal of wisdom teeth; and
5261
5362 WHEREAS, Each day in the United States, 580 people initiate heroin use; and
5463
5564 WHEREAS, Opioid use and misuse can create brain changes that lead to addiction; and
5665
5766 WHEREAS, Most people who are addicted to opioids cannot taper off, or use less of the drug over time, without help; and
5867
5968 WHEREAS, The long-term damage to individuals and families is highly detrimental; and
6069
6170 WHEREAS, The Centers for Disease Control and Prevention recommends nonopioid pharmacologic therapy and if opioids are used, they should be combined with nonopioid therapy, as appropriate; and
6271
6372 WHEREAS, In 2016, the federal Interagency Pain Research Coordinating Committee developed a National Pain Strategy, noting that effective pain care must emphasize shared decisionmaking, informed pain assessment, and integrated, multimodal, and interdisciplinary treatment approaches that balance effectiveness with safety; and
6473
6574 WHEREAS, Each year, a week in September is designated as national Prescription Opioid and Heroin Epidemic Awareness Week; now, therefore, be it
6675
6776 Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature designates the month of September 2019 as Opioid, Heroin, Fentanyl, and Prescription Drug Abuse Awareness Month and encourages residents to show support for opioid and prescription drug awareness; and be it further
6877
6978 Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.